WO2011121596A3 - Crystal modification of moxifloxacin hydrochloride - Google Patents

Crystal modification of moxifloxacin hydrochloride Download PDF

Info

Publication number
WO2011121596A3
WO2011121596A3 PCT/IN2010/000220 IN2010000220W WO2011121596A3 WO 2011121596 A3 WO2011121596 A3 WO 2011121596A3 IN 2010000220 W IN2010000220 W IN 2010000220W WO 2011121596 A3 WO2011121596 A3 WO 2011121596A3
Authority
WO
WIPO (PCT)
Prior art keywords
moxifloxacin hydrochloride
crystal modification
moxifloxacin
hydrochloride
manufacturing
Prior art date
Application number
PCT/IN2010/000220
Other languages
French (fr)
Other versions
WO2011121596A2 (en
Inventor
Arul Ramakrishnana
Sreenivasulu Pamujula
Original Assignee
Neuland Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuland Laboratories Ltd. filed Critical Neuland Laboratories Ltd.
Priority to PCT/IN2010/000220 priority Critical patent/WO2011121596A2/en
Publication of WO2011121596A2 publication Critical patent/WO2011121596A2/en
Publication of WO2011121596A3 publication Critical patent/WO2011121596A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention related to novel polymorphic forms of Moxifloxacin hydrochloride and an improved industrially viable, cost effective process for their manufacturing.
PCT/IN2010/000220 2010-04-01 2010-04-01 Crystal modification of moxifloxacin hydrochloride WO2011121596A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IN2010/000220 WO2011121596A2 (en) 2010-04-01 2010-04-01 Crystal modification of moxifloxacin hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2010/000220 WO2011121596A2 (en) 2010-04-01 2010-04-01 Crystal modification of moxifloxacin hydrochloride

Publications (2)

Publication Number Publication Date
WO2011121596A2 WO2011121596A2 (en) 2011-10-06
WO2011121596A3 true WO2011121596A3 (en) 2016-05-26

Family

ID=44712697

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000220 WO2011121596A2 (en) 2010-04-01 2010-04-01 Crystal modification of moxifloxacin hydrochloride

Country Status (1)

Country Link
WO (1) WO2011121596A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104277059A (en) * 2013-07-01 2015-01-14 广东东阳光药业有限公司 Preparation method of fluoroquinolone antibacterial drug
CN108690021A (en) * 2018-07-09 2018-10-23 宋雪萍 A kind of preparation method and its pharmaceutical composition of moxifloxacin hydrochloride
CN110903285A (en) * 2019-12-13 2020-03-24 南京恒道医药科技有限公司 Method for producing moxifloxacin side chain by using secondary rectification

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849752A (en) * 1995-12-12 1998-12-15 Bayer Aktiengesellschaft Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
US20050001001A1 (en) * 2003-06-20 2005-01-06 Yoshihiro Nakano Fastener driving tool having contact arm in contact with workpiece
US20050137227A1 (en) * 2003-04-09 2005-06-23 Dr. Reddy's Laboratories Limited Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
US20070001007A1 (en) * 1990-01-18 2007-01-04 Koenck Steven E Modular, Portable Data Processing Terminal for Use in a Radio Frequency Communication Network
WO2008059223A2 (en) * 2006-11-13 2008-05-22 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
US20090001025A1 (en) * 2007-06-29 2009-01-01 Chisso Corporation Aggregation and dispersion methods of magnetic particles, separation and detection methods using the same and detection kit
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070001007A1 (en) * 1990-01-18 2007-01-04 Koenck Steven E Modular, Portable Data Processing Terminal for Use in a Radio Frequency Communication Network
US5849752A (en) * 1995-12-12 1998-12-15 Bayer Aktiengesellschaft Crystal modification of CDCH a process for its preparation and pharmaceutical formulations comprising this modification
US20050137227A1 (en) * 2003-04-09 2005-06-23 Dr. Reddy's Laboratories Limited Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for preparation thereof
US20050001001A1 (en) * 2003-06-20 2005-01-06 Yoshihiro Nakano Fastener driving tool having contact arm in contact with workpiece
US7589128B2 (en) * 2004-06-01 2009-09-15 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Process for preparation of amorphous form of a drug
WO2008059223A2 (en) * 2006-11-13 2008-05-22 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
US20090001025A1 (en) * 2007-06-29 2009-01-01 Chisso Corporation Aggregation and dispersion methods of magnetic particles, separation and detection methods using the same and detection kit

Also Published As

Publication number Publication date
WO2011121596A2 (en) 2011-10-06

Similar Documents

Publication Publication Date Title
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
EP2751060A4 (en) Process for producing both biobased succinic acid and 2,5-furandicarboxylic acid
PL2630108T3 (en) Process for the preparation of 2,3,3,3 tetrafluoropropene
WO2012122011A3 (en) Amino-quinolines as kinase inhibitors
PL2791093T3 (en) Process for the preparation of 2, 3, 3, 3 tetrafluoropropene
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
IL230635A (en) 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
PL2360137T3 (en) Process for manufacturing succinic acid
WO2012061037A3 (en) Method for preparing small crystal ssz-32
HRP20170600T2 (en) Process for the production of biscuits having improved organoleptic properties
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
ZA201103390B (en) Process for the manufacture of p4o6 with high yield
AU2009254929A8 (en) An improved process for the preparation of amines
WO2015068175A3 (en) An improved process for the preparation of pazopanib or a pharmaceutically acceptable salt thereof
WO2013102919A8 (en) Polymorphic forms of ivabradine hydrochloride
HK1199242A1 (en) Process for the production of 1,3-butadiene 13-
WO2013072933A3 (en) Process for preparation of 2-acetamido-n-benzyl-3-methoxypropionamide
WO2012176214A3 (en) Process for bendamustine hydrochloride
WO2011018771A3 (en) Process for the preparation of valganciclovir hydrochloride
WO2010121877A3 (en) Process for the preparation of olopatadine
WO2010027848A3 (en) Forms of lapatinib compounds and processes for the preparation thereof
WO2011121596A3 (en) Crystal modification of moxifloxacin hydrochloride
WO2013072938A3 (en) Process for the preparation of roflumilast
IL226132B (en) Process for the preparation of substituted n-(benzyl) cyclopropanamines by imine hydrogenation
WO2014064714A3 (en) Process for preparation of lurasidone hydrochloride

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10848807

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10848807

Country of ref document: EP

Kind code of ref document: A2